International Markets and The Cooper Companies (COO): A Deep Dive for Investors

Cooper Companies reported Q3 2026 revenue of $1.07 billion, up just 0.6% year-over-year, signaling a sharp growth deceleration for the medical device maker. The company's EMEA region delivered $309.4 million—29% of total revenue—beating analyst estimates by 1.93%. Asia Pacific underperformed, generating $126 million (11.8% of revenue) and missing forecasts by 6.14%.

Zacks Investment Research slapped COO with a Rank #5 (Strong Sell) rating. The stock has cratered 29.2% over the past month, a dramatic underperformance against the S&P 500's 0.8% decline in the same period. The firm cited currency headwinds and geopolitical risks as key pressure points.

The divergence between EMEA strength and Asia Pacific weakness highlights regional execution risk at a time when revenue growth has nearly flatlined. The magnitude of the one-month selloff suggests investors are pricing in deteriorating fundamentals beyond near-term FX volatility.